Bolni Marius Nagalo

PhD

Consultant

Assistant Professor, Assistant Professor of Molecular Medicine (Mayo Clinic College of Medicine and Science), Assistant Professor of Pathology (University of Arkansas)

Dr. Nagalo was a principal investigator in the following studies:

  1. cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma;
  2. Virally Induced Alloreactivity for Treatment of Hepatocellular Carcinoma. Development of a gene therapy approach for Treatment of Treatment of Hepatocellular Carcinoma (HCC);
  3. Hybrid oncolytic VSV for the treatment of pancreatic cancer;
  4. Generation of a Synthetic Biology-enabled Vesiculovirus to Treat Soft Tissue Sarcoma (sts);
  5. Hybrid Vesiculovirus Library to Enhance Oncolytic Viral Therapy in Acute Myeloid Leukemia (AML);
  6. Mayo Clinic Pancreatic Cancer SPORE (co-Investigator) Combination Therapy with Oncolytic Virus and CAR-T in Advanced Pancreatic Cancer;
  7. Preclinical study of novel oncolytic adenovirus to treat advanced HCC.

Resume submission form